Summary
The prevalence of glutamic acid decarboxylase autoantibodies was determined with an immunotrapping enzyme activity assay in newly-diagnosed Type 1 (insulin-dependent) diabetic patients as well as in first-degree relatives using rat brain homogenate as a source of glutamate decarboxylase. Twenty-six out of 86 islet-cell cytoplasmic autoantibody positive and one out of 24 islet cell autoantibody negative patients of recent onset, had autoantibodies to glutamate decarboxylase above the upper 99% confidence limit obtained from 89 control sera. Among 27 islet cell autoantibody positive relatives including 19 siblings and 8 parents, antibodies to glutamate decarboxylase were found in 8 of 9 (89%) relatives and 7 of 8 (87.5%) siblings with islet cell autoantibody titres above 20 JDF units, in 1 of 19 (5.2%) relatives with islet cell autoantibody titres between 2 and 5 JDF units, in 2 of 263 (0.7%) siblings and 1 of 139 parents without islet cell autoantibodies. In first-degree relatives, high titre islet cell autoantibodies and autoantibodies to glutamate decarboxylase were tightly associated (X2=182, p=0.0001). None of the relatives with low genetic risk (n=64), i.e. HLA-different to the diabetic proband, was found to be antibody positive. Antibodies to glutamate decarboxylase were present only in those relatives sharing at least one haplotype with the diabetic proband, including two islet cell autoantibody negative but HLA-identical siblings. Autoantibodies to glutamate decarboxylase were present in 7 of 9 (77%) relatives who developed the disease, including one islet cell autoantibody negative sibling. Altogether, the simultaneous presence of autoantibodies to glutamate decarboxylase and high titre islet cell autoantibody increases the positive predictive value for the disease from 66% to 75%. This study indicates therefore that autoantibodies to glutamate decarboxylase detected by an immunotrapping enzyme activity assay are additional predictive markers for future development of Type 1 diabetes and should be now prospectively studied in high risk individuals as well as other autoantibodies to Beta-cell autoantigens.
Article PDF
Similar content being viewed by others
References
Castano L, Eisenbarth GS (1990) Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Ann Rev Immunol 8: 647–679
Todd JA (1990) Genetic control of autoimmunity in Type 1 diabetes. Immunol Today 11: 122–129
Tarn AC, Thomas JM, Dean BM et al. (1988) Predicting insulin dependent diabetes. Lancet I: 845–850
Thivolet CH, Beaufrère B, Betuel H et al. (1988) Islet cell and insulin autoantibodies in individuals at high risk of development of Type 1 (insulin-dependent) diabetes mellitus: the Lyon's family study. Diabetologia 31: 741–746
Bonifacio E, Bingley PJ, Shattock M et al. (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet I 335: 147–149
Thivolet CH, Beaufrère B, Geburher L et al. (1991) Autoantibodies and genetic factors associated with development of Type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 34: 186–191
Bougnères PF, Carel JC, Castano L et al. (1988) Factors associated with early remission of Type 1 diabetes in children treated with cyclosporine. N Engl J Med 318: 663–670
Oertel WH, Schmechel DE, Tappaz ML, Kopin IJ (1981) Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience 6: 2689–2700
Solimena M, Folli F, Denis-Domini S, Comi GC, Pozza G (1988) Autoantibodies to Glutamic Acid Decarboxylase in a patient with Stiff-man syndrome, epilepsy, and Type 1 diabetes mellitus. N Engl J Med 318: 1012–1020
Williams AC, Nutt JG, Hare T (1988) Autoimmunity in stiff-man syndrome. Lancet II: 222
Solimena M, Folli F, Aparasi R, Pozza G, De Camilli P (1990) Autoantibodies to Gaba-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322: 1555–1560
Vincent SR, Hökfelt T, Wu JY, Elde RP, Morgan LM, Kimmel JR (1983) Immunohistochemical studies of the GABA system in the pancreas. Neuroendocrinology 36: 197–204
Okada Y, Hosoya Y, Taniguchi H (1976) High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma. Science 194: 620–622
Reetz A, Solimena M, Matteoli M, Takei K, De Camilli P (1991) GABA and pancreatic β cells: colocalization of Glutamic acid Decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10: 1275–1284
Cram DS, Barnett LD, Joseph JL, Harrison LC (1991) Cloning and partial nucleotide sequence of human Glutamic Acid Decarboxylase cDNA from brain and pancreatic islets. Biochem Biophys Res Commun 176: 1239–1244
Baekkeskov S, Aanstoot HH, Christgau S et al. (1990) Identification of the 64 kD autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151–156
Michelsen BK, Petersen JS, Boel E, Moldrup A, Dyrberg T, Madsen OD (1991) Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulindependent diabetes mellitus. Proc Natl Acad Sci USA 88: 8754–8758
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A (1982) Autoantibodies in newly-diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins. Nature 298: 167–169
Baekkeskov S, Landin M, Kristensen JK et al. (1987) Antibodies to a Mr 64.000 human islet cell antigen precede the clinical onset of diabetes. J Clin Invest 79: 926–934
Atkinson MA, MacLaren N, Sharp D, Lacy PE, Riley WJ (1990) 64,000 M autoantibodies as predictors of insulin-dependent diabetes. Lancet II: 1357–1360
Atkinson MA, Maclaren NK (1988) Autoantibodies innonobese diabetic mice immunoprecipitate 64.000-Mr islet antigen. Diabetes 37: 1587–1590
Legay F, Henry S, Tappaz M (1987) Evidence of two distinct forms of native glutamic acid decarboxylase in rat brain soluble extract: an immunoblotting study. J Neurochem 48: 1022–1026
Erlander MG, Tillakaratna NJ, Feldblum S, Patel N, Tobin AJ (1991) Two genes encode distinct glutamate decarboxylase. Neuron 7: 91–100
Kaufman DL, Erlander MG, Clare-Salzer M, Atkinson MA, MacLaren NK, Tobin AJ (1992) Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 89: 283–292
Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL (1990) Distinct antibody specificities to a 64 kD islet cell antigen in Type 1 diabetes as revealed by trypsin treatment. J Exp Med 172: 789–794
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thivolet, C.H., Tappaz, M., Durand, A. et al. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35, 570–576 (1992). https://doi.org/10.1007/BF00400486
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400486